UNSPSC 51392225: Medetomidine hydrochloride

This classification denotes an alpha-adrenergic agonist with the molecular formula C13H16N2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BH210P244U, chemically known as 1h-imidazole, 4-(1-(2,3-dimethylphenyl)ethyl)-, monohydrochloride, (+-)- but more generally known as medetomidine hydrochloride, which bears US NIH Compound Identifier 68601. Most nations, for tariff and trade purposes, schedule medetomidine hydrochloride under HS 29332990 and SITC 51573.

As of Q4 2014, MEDETOMIDINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Medetomidine hydrochloride bears US NLM identifiers UMLS ID C0065852 and NCI Concept Code C81368. SMILES: CC1CCCC(C1C)C(C)C2C[NH]CN2.CL.

UNSPSC 51392225 Medetomidine hydrochloride is a Commodity code that reflects state and local procurement of pharmaceutical products, though recent sourcing activity shows a mismatch between the code's nominal scope and actual buying patterns. The single recent opportunity in the record—Seminole County, Florida's IFB60459723LAS—requests naloxone and safe drug deactivation systems rather than medetomidine hydrochloride. The county is procuring 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding to support community health initiatives. Vendors must submit electronic bids through the county's e-Procurement Portal with all shipping and delivery costs included, comply with drug-free workplace and E-Verify requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract runs two years with an optional one-year renewal and includes a three-month probationary period.

The geographic spread and issuing-body mix are limited by the available record. Seminole County, a Florida county government, is the sole recent buyer identified. The IFB closed on July 26, 2023, with quarterly deliveries required to the Seminole County Community Health Building in Sanford, Florida. The procurement appears to be partially funded through FEMA, introducing additional compliance requirements including adherence to the Clean Air Act and Federal Water Pollution Control Act. No explicit set-aside designations for disadvantaged enterprises are mentioned. Given that the single recent opportunity under this code involves naloxone procurement rather than medetomidine hydrochloride, the code shows little relevant recent activity for vendors focused on the pharmaceutical product its name suggests.